Humanigen Inc (HGENQ)

[Knuckle Sandwich]

I think it's coming in a sweeping EUA for multiple Mab's, probably see the Two Big names that keep getting attention and a blurb about Humanigen as the third. However, I still think Gilead will sweep the leg and make a move here to combine Lenzilumab with Remdesivir in Covid as well as the obvious Car-T angle. It's my guess but Lenzilumab gives them more name recognition where they have been doing the hard work with Remdesivir and keeps them relevant in this area.